Quotables
"There is practically no chance communications space satellites will be used to provide better telephone, telegraph, television, or radio service inside the United States."
T. Craven, FCC Commissioner ; 1961
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120107252 | METHOD FOR FORMING CYCLODEXTRIN POLYMER AND LIPOPHILIC COMPOUND EMULSIONS, RESULTING EMULSIONS, AND COMPOSITIONS INCLUDING SAID EMULSIONS The present invention relates to a method for preparing a cyclodextrin polymer and/or a hydrophilic polymer emulsion having cyclodextrins as well as lipophilic compounds, the emulsions having a remarkable stability. In particular, the method includes: (i) adding a lipop... | 05/03/2012 |
| 20120083467 | DEODORANT COMPOSITIONS A deodorant composition contains β-cyclodextrin, a fixative, a preservative, and a solvent.... | 04/05/2012 |
| 20120070508 | Methods, Compositions, and Devices for Managing Chlorine Dioxide Release Certain exemplary embodiments can provide a system, machine, device, manufacture, circuit, composition of matter, and/or user interface adapted for and/or resulting from, and/or a method and/or machine-readable medium comprising machine-implementable instructions for, a... | 03/22/2012 |
| 20120053145 | ARIPIPRAZOLE COMPLEX FORMULATION AND METHOD An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a β-cyclodextrin, preferably, sulfobutyl ether β-cyclodextrin (SBECD), which in the form of an injectable produces reversible generally m... | 03/01/2012 |
| 20120035130 | Chirally Correct Retinal Cyclodextrin Acetals for Clarifying Skin Complexion The present invention discloses certain chirally correct polyene cyclodextrin acetals and hemiacetals (formula I) that are effective in providing skin clarification, which is useful for the treatment of acne, and skin disfigurements and skin darkening resulting from acn... | 02/09/2012 |
| 20120028918 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING SAME The present invention relates to pharmaceutical compositions that include about 10 mg pazopanib/mL of the composition and about 2 to about 13% w/w of a modified cyclodextrin as well as methods of making the same are described.... | 02/02/2012 |
| 20120017924 | COATED NICOTINE-CONTAINING CHEWING GUM, MANUFACTURE AND USE THEREOF A coated chewing gum product for the delivering of nicotine in any form to a subject by a rapid transmucosal uptake in the oral cavity comprising at least one gum core, nicotine in any form and/or a nicotine mimicking agent, at least one coating layer and optionally at ... | 01/26/2012 |
| 20120015039 | SUSTAINED RELEASE OF NUTRIENTS IN VIVO Nutritional compositions delivered in vivo in a time controlled manner sustainable over long periods of time, provide enhancing athletic performance, increased hand/eye coordination and concentration on the task at hand.... | 01/19/2012 |
| 20120004158 | Quaternised Ammonium Cyclodextrin Compounds Use of a compound of formula (I):
01/05/2012 | |
| 20120004195 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY Methods and compositions relating to CDP-proteasome inhibitor conjugates are described herein.... | 01/05/2012 |
| 20110312914 | CARBON MONOXIDE REMOVAL AGENT The present invention provides a carbon monoxide removal agent that can be easily administered to a patient by injection or orally. The carbon monoxide removal agent of the present invention contains, as an active ingredient, an inclusion complex in which a cyclodextrin... | 12/22/2011 |
| 20110305685 | SUPRAMOLECULAR APPROACH FOR PREPARATION OF SIZE CONTROLLABLE NANOPARTICLES A supramolecular approach has been developed for preparation of size-controllable nanoparticles, from three different molecular building blocks.... | 12/15/2011 |
| 20110305639 | METHOD AND FORMULATION FOR REDUCING AGGREGATION OF A MACROMOLECULE UNDER PHYSIOLOGICAL CONDITIONS The invention provides a method for reducing aggregation and inhibiting flocculation of a macromolecule, such as a protein, under physiological conditions, by the addition of certain cyclodextrins (CDs). The invention also provides a method to minimize inflammation at t... | 12/15/2011 |
| 20110300150 | COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASE Provided are methods relating to the use of CDP-therapeutic agent conjugates for the treatment of autoimmune disease, inflammatory disease, or cancer. Also provided are CDP-therapeutic agent conjugates, particles comprising CDP-therapeutic agent conjugates, and composit... | 12/08/2011 |
| 20110293537 | FORMULATIONS WITH ANTI-NEOPLASTIC ACTIVITY Pharmaceutical formulation comprising at least one aryl hydrocarbon receptor ligand and at least one cyclodextrin for the prevention and/or treatment of carcinomas, preferably squamous cell carcinomas, more preferably oral squamous cell carcinomas.... | 12/01/2011 |
| 20110288049 | Compositions, Systems, and/or Methods Involving Chlorine Dioxide ("ClO2") Certain exemplary embodiments can provide a composition of matter comprising a solid form of chlorine dioxide complexed with a cyclodextrin. The concentration of chlorine dioxide in said solid form is greater than approximately 5.8 percent by weight. Certain exemplary e... | 11/24/2011 |
| 20110275594 | Oral dosage form A pharmaceutical or nutraceutical tablet for oral administration comprising at least two fatty acids or derivatives thereof and cyclodextrin.... | 11/10/2011 |
| 20110263528 | ANTIMICROBIAL COMPOSITIONS This invention provides antimicrobial compositions containing methylglyoxal and material with methylglyoxal contained (such as manuka honey). The antimicrobial activity of methylglyoxal, or material with a methylglyoxal presence, is maintained and/or enhanced by mixing ... | 10/27/2011 |
| 20110262378 | Rifaximin Complexes There is provided a complex comprising rifaximin and a complexing agent, wherein the complexing agent is a polyvinyl pyrrolidone (PVP) or a cyclodextrin. There is also provided a process for preparing the complex, a pharmaceutical composition including the complex, and ... | 10/27/2011 |
| 20110256104 | COMPLEXING AGENTS FOR COMPOSITIONS CONTAINING INCLUSION COMPLEXES The invention provides a composition containing particulate composite of a polymer and a therapeutic agent. The composition also contains a complexing agent. The polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion... | 10/20/2011 |
| 20110257126 | WATER SOLUBLE CURCUMIN COMPOSITIONS FOR USE IN ANTI-CANCER AND ANTI-INFLAMMATORY THERAPY The present invention relates to the medical field. In a first aspect the present invention relates to novel water soluble cyclodextrin-curcumin complexes having a pharmacological activity, in particular an anti-tumour and/or anti-inflammatory activity, and improved phy... | 10/20/2011 |
| 20110251157 | Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid An inhalable formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The formulation can be included in a kit. The formulation is administered as an aqueous soluti... | 10/13/2011 |
| 20110245201 | TREATMENT OF CANCER Provided are methods relating to compositions that include a CDP-topoisomerase inhibitor, e.g., a CDP-camptothecin or camptothecin derivative conjugate, e.g., CRLX101.... | 10/06/2011 |
| 20110237540 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY Methods and compositions relating to CDP-taxane conjugates are described herein.... | 09/29/2011 |
| 20110236505 | CARBOHYDRATE BAR The present invention generally relates to the field of nutrition, in particular performance nutrition. In particular, the present invention relates to a novel carbohydrate bar comprising glucose and fructose in a ratio in the range of 3:1 to 1:1. The carbohydrate bar o... | 09/29/2011 |
| 20110237541 | TRANSDERMALLY ADMINISTERED ALISKIREN Dosage form of aliskiren, comprising a device for transdermal administration of aliskiren and aliskiren (including salts, prodrugs and metabolites thereof), optionally together with pharmaceutically acceptable carrier(s) to a human being or an animal in order to achieve... | 09/29/2011 |
| 20110224168 | FAT-BINDING COMPOSITIONS A fat-binding composition contains an inclusion complex with a host molecule and a guest molecule. The guest molecule includes one or more amino acids, vitamins, flavorants or related compounds, rutin, betanin, derivatives thereof, and mixtures thereof. The fat-binding ... | 09/15/2011 |
| 20110217339 | MUCOACTIVE AGENTS FOR TREATING A PULMONARY DISEASE The present invention relates to pharmaceutical compositions which are useful in the treatment of diseases where excess mucus is present in the respiratory tract, such as cystic fibrosis and chronic obstructive pulmonary disease. In particular, the invention relates to ... | 09/08/2011 |
| 20110218173 | INCLUSION COMPLEXES OF PINOCEMBRIN WITH CYCLODEXTRIN OR ITS DERIVATIVES Inclusion complexes of pinocembrin with cyclodextrin or its derivatives and their preparation are provided. The inclusion complexes can be used to make drugs.... | 09/08/2011 |
| 20110207697 | XANTHOHUMOL COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES OR DISORDERS The present invention features therapeutic and prophylactic compositions comprising xanthohumol and/or xanthohumol/cyclodextrin complexes and methods of using such compositions for treating a skin condition, disease, or disorder.... | 08/25/2011 |
| 20110200581 | PHARMACEUTICAL COMPOSITIONS Synthesis natural tubulisine derivatives of formula (A) having a high cytotoxicity wherein:
| |
| 20110172182 | Carboxyethylated Cyclodextrin Polysulfates Useful As Medicaments This invention relates to novel β-cyclodextrin polysulfate compounds comprising from one to three 2-carboxyethyl substituents, and at least two sulfates groups per glucopyranose unit, which are useful as active ingredients for the treatment and/or prophylaxis of degene... | 07/14/2011 |
| 20110160159 | TREATMENT OF CANCER Provided are methods relating to compositions that include a CDP-topoisomerase inhibitor, e.g., a CDP-camptothecin or camptothecin derivative conjugate, e.g., CRLX101.... | 06/30/2011 |
| 20110152216 | ANAESTHETIC COMPOSITION A stable anaesthetic composition is described which is particularly suitable for use in cats and dogs. The composition comprises an aqueous solution of an anaesthetically effective amount of a water soluble cyclodextrin or a cyclodextrin derivative complex of alfaxalone... | 06/23/2011 |
| 20110144053 | Process for Obtaining Purified Pterostilbene and Methods of Use Thereof The present invention relates to a process of extraction and purification of a stilbenoid, pterostilbene, from botanical sources. The process involves obtaining pterostilbene having high degree of purity and the present invention also relates to pure form of pterostilbe... | 06/16/2011 |
| 20110123501 | GUT FLORA AND WEIGHT MANAGEMENT The present invention relates to supporting weight management, weight loss and/or to the prevention and/or treatment of metabolic disorders. In particular the present invention relates to preventing and/or treating metabolic disorders by modulating, in particular reduci... | 05/26/2011 |
| 20110117144 | Topical cosmetic preparation containing elastogenesis inducing substances associated with a systemic absorption retardant A cosmetic/dermatological topical preparation such as a cream or ointment or lotion containing elastogenesis inducing substances such as a dill extract or Ethocyn associated with a systemic absorption retardant such as a mixture of Benzyl Alcohol, Acetone and Isopropano... | 05/19/2011 |
| 20110091541 | Preparation of formulations of angiotensin II at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications Preparation of AT1 receptors antagonists formulations using the cyclodextrins, their derivatives and/or biodegradable polymers for the treatment of arterial hypertension, other cardiovascular disease and their complications. Until now, no applications using the AT1... | 04/21/2011 |
| 20110086815 | NOVEL COMPOSITIONS CONTAINING XANTHOHUMOL-CYCLODEXTRIN COMPLEXES The invention provides compositions comprising xanthohumol/cyclodextrin complexes that are water soluble and that have increased stability relative to xanthohumol alone.... | 04/14/2011 |
| 20110082105 | COMPOSITIONS COMPRISING SUPERHYDROPHILIC AMPHIPHILIC COPOLYMERS AND METHODS OF USE THEREOF Provided are compositions comprising a superhydrophilic amphiphilic copolymer and a carrier and composition comprising a superhydrophilic amphiphilic copolymer, a micellar thickener and a carrier.... | 04/07/2011 |
